Synthesis, spectral characterisation, biocidal investigation, in-silico and molecular docking studies of 4-[(2-chloro-4-methylphenyl)carbamoyl]butanoic acid derived triorganotin(IV) compounds.
暂无分享,去创建一个
E. Tiekink | A. Bari | A. Wadood | Ishaq N. Khan | S. Shams | M. Kubicki | Bibi Hanifa | M. Sirajuddin | Naila Bibi
[1] M. I. Faizan,et al. Design and Synthesis of Carbothioamide/Carboxamide-Based Pyrazoline Analogs as Potential Anticancer Agents: Apoptosis, Molecular Docking, ADME Assay, and DNA Binding Studies , 2022, ACS omega.
[2] N. El‐Metwaly,et al. Synthesis and Investigation of Bivalent Thiosemicarbazone Complexes: Conformational Analysis, Methyl Green DNA Binding and In-silico Studies , 2022, Arabian Journal for Science and Engineering.
[3] Ashwani Kumar,et al. Synthesis, spectral studies, in vitro antimicrobial activity and molecular docking studies of organotin(IV) complexes derived from tridentate Schiff base ligands , 2022, Research on Chemical Intermediates.
[4] E. Tiekink,et al. Three isomeric 4-[(n-bromophenyl)carbamoyl]butanoic acids (n = 2, 3 and 4) as DNA intercalator: Synthesis, physicochemical characterization, antimicrobial activity, antioxidant potential and in silico study , 2022, Journal of Molecular Structure.
[5] E. Tiekink,et al. Designing, Physiochemical Confirmation, Evaluation of Biological and in-silico Potential of Triorganotin(IV) Complexes , 2022, Journal of Molecular Structure.
[6] V. Zoete,et al. The SwissSimilarity 2021 Web Tool: Novel Chemical Libraries and Additional Methods for an Enhanced Ligand-Based Virtual Screening Experience , 2022, International journal of molecular sciences.
[7] M. Tariq,et al. Synthesis, characterization, POM analyses and biological evaluation of n-[(2-methoxy-5- nitrophenyl)]-4-oxo-4-[oxy] butenamide based zinc(II) carboxylate complexes , 2021, Bulletin of the Chemical Society of Ethiopia.
[8] M. Tillard,et al. Two novel macrocyclic organotin (IV) carboxylates based on bipyrazoledicarboxylic acid derivatives: syntheses, crystal structures and antifungal activities , 2021, Journal of Organometallic Chemistry.
[9] M. Zacharias,et al. Accurate modeling of DNA conformational flexibility by a multivariate Ising model , 2021, Proceedings of the National Academy of Sciences.
[10] Guillermo M. Chans,et al. Design of Promising Heptacoordinated Organotin (IV) Complexes-PEDOT: PSS-Based Composite for New-Generation Optoelectronic Devices Applications , 2021, Polymers.
[11] Saqib Ali,et al. Organotin(IV) derivatives based on 2-((2-methoxyphenyl)carbamoyl)benzoic acid: Synthesis, spectroscopic characterization, assessment of antibacterial, DNA interaction, anticancer and antileishmanial potentials , 2020 .
[12] E. Tiekink,et al. Crystal structure of 4-[(3,5-dichlorophenyl)carbamoyl]butanoic acid, C11H11Cl2NO3 , 2020 .
[13] E. Tiekink,et al. Crystal structure of 4-[(3-methoxyphenyl)carbamoyl]butanoic acid, C12H15NO4 , 2020 .
[14] E. Tiekink,et al. Crystal structure of 4-[(2-methoxyphenyl)carbamoyl]butanoic acid, C12H15NO4 , 2020 .
[15] P. Zhan,et al. Fsp3: A new parameter for drug-likeness. , 2020, Drug discovery today.
[16] Manoj Kumar,et al. Organotin Complexes with Promising Therapeutic Potential , 2020, Current Pharmacology Reports.
[17] E. Steliarova-Foucher,et al. Scaling up the surveillance of childhood cancer: a global roadmap. , 2020, Journal of the National Cancer Institute.
[18] Shaukat Ali,et al. Exploration of biological potency of carboxylic acid derivatives: Designing, synthesis, characterizations and molecular docking study , 2020 .
[19] Reaz Uddin,et al. Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach , 2020, Journal of biomolecular structure & dynamics.
[20] Sonia Lobo,et al. Is there enough focus on lipophilicity in drug discovery? , 2019, Expert opinion on drug discovery.
[21] Saqib Ali,et al. Spectroscopic characterizations, structural peculiarities, molecular docking study and evaluation of biological potential of newly designed organotin(IV) carboxylates. , 2019, Journal of photochemistry and photobiology. B, Biology.
[22] Peng Zhan,et al. Overview of Recent Strategic Advances in Medicinal Chemistry. , 2019, Journal of medicinal chemistry.
[23] Saqib Ali,et al. Exploration of organotin(IV) derivatives for medicinal applications: Synthesis, spectroscopic characterization, structural elucidation and molecular docking study , 2019, Journal of Molecular Structure.
[24] Saqib Ali,et al. Synthesis, characterization, biological screenings and molecular docking study of Organotin(IV) derivatives of 2,4-dichlorophenoxyacetic acid , 2019, Journal of Molecular Structure.
[25] Saqib Ali,et al. Synthesis, spectroscopic characterization, crystal structure, interaction with DNA, CTAB as well as evaluation of biological potency, docking and Molecular Dynamics studies of N-(3,4,5-trimethoxybenzylidene)-2, 3-dimethylbenzenamine , 2019, Journal of Molecular Structure.
[26] Asma Sindhoo Nangraj,et al. Structural-dynamic insights into the H. pylori cytotoxin-associated gene A (CagA) and its abrogation to interact with the tumor suppressor protein ASPP2 using decoy peptides , 2018, Journal of biomolecular structure & dynamics.
[27] Saqib Ali,et al. Synthesis, physicochemical characterizations and in vitro biological evaluations of amide based Zn(II) carboxylates , 2018, Inorganica Chimica Acta.
[28] Seema Joshi,et al. Computer-aided drug design and virtual screening of targeted combinatorial libraries of mixed-ligand transition metal complexes of 2-butanone thiosemicarbazone , 2018, Comput. Biol. Chem..
[29] S. Etaiw,et al. Structure and applications of organotin complex based on trimethyltin cation and quinaldic acid , 2018 .
[30] J. Takahashi,et al. Spectroscopic and X‐ray structural characterization of new polymeric organotin(IV) carboxylates and their in vitro antifungal activities: Part II , 2017 .
[31] Olivier Michielin,et al. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules , 2017, Scientific Reports.
[32] Saqib Ali,et al. Organotin(IV) Carboxylates as Promising Potential Drug Candidates in the Field of Cancer Chemotherapy. , 2017, Current pharmaceutical design.
[33] M. Cooper,et al. Chemical philanthropy: a path forward for antibiotic discovery? , 2016, Future medicinal chemistry.
[34] M. Cooper,et al. Helping Chemists Discover New Antibiotics. , 2015, ACS infectious diseases.
[35] Haruki Nakamura,et al. Prediction of Synthetic Accessibility Based on Commercially Available Compound Databases , 2014, J. Chem. Inf. Model..
[36] Olivier Michielin,et al. iLOGP: A Simple, Robust, and Efficient Description of n-Octanol/Water Partition Coefficient for Drug Design Using the GB/SA Approach , 2014, J. Chem. Inf. Model..
[37] Richard A. Taylor,et al. Theories and experimental investigations of the structural and thermotropic mesomorphic phase behaviors of metal carboxylates , 2014, Applied Petrochemical Research.
[38] Saqib Ali,et al. Drug-DNA interactions and their study by UV-Visible, fluorescence spectroscopies and cyclic voltametry. , 2013, Journal of photochemistry and photobiology. B, Biology.
[39] Saqib Ali,et al. Synthesis, characterization, biological screenings and interaction with calf thymus DNA of a novel azomethine 3-((3,5-dimethylphenylimino)methyl)benzene-1,2-diol. , 2012, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.
[40] Saqib Ali,et al. Synthesis, characterization, biological screenings and interaction with calf thymus DNA as well as electrochemical studies of adducts formed by azomethine [2-((3,5-dimethylphenylimino)methyl)phenol] and organotin(IV) chlorides , 2012 .
[41] M. Waring. Lipophilicity in drug discovery , 2010, Expert opinion on drug discovery.
[42] E. Tiekink. Tin Dithiocarbamates: Applications and Structures , 2008 .
[43] Y. Martin,et al. A bioavailability score. , 2005, Journal of medicinal chemistry.
[44] John S. Delaney,et al. ESOL: Estimating Aqueous Solubility Directly from Molecular Structure , 2004, J. Chem. Inf. Model..
[45] Stephen R. Johnson,et al. Molecular properties that influence the oral bioavailability of drug candidates. , 2002, Journal of medicinal chemistry.
[46] I. Muegge,et al. Simple selection criteria for drug-like chemical matter. , 2001, Journal of medicinal chemistry.
[47] J J Baldwin,et al. Prediction of drug absorption using multivariate statistics. , 2000, Journal of medicinal chemistry.
[48] M. Gielen. Tin-based Antitumour Drugs , 1996, NATO ASI Series.
[49] E. M. Holt,et al. Solution and solid-state molecular structures of Me2Sn(OAc)2 and its hydrolyzate, ([Me2Sn(OAc)]2O)2, by solution and solid-state carbon-13 NMR. X-ray diffraction study of the hydrolyzate , 1986 .
[50] OUP accepted manuscript , 2021, Nucleic Acids Research.
[51] A. Garza-Ortiz,et al. Synthesis, structural characterization and in vitro cytotoxic activity of novel polymeric triorganotin(IV) complexes of urocanic acid , 2013 .
[52] N. Hadjiliadis,et al. Antiproliferative and anti-tumor activity of organotin compounds , 2009 .
[53] A. Ghose,et al. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. , 1999, Journal of combinatorial chemistry.